Yes, that could be the reason for the bump. Reading through the article, it appears there might be a threat to Cryoports lunch though...that being treatment at the bedside, sounds like they are not very thrilled to have to ship the cells back and forth, so they are developing portable machines that process the cells they can take with them, which is probably why no attention was brought to the article. I can't see how that is very efficient either though. Should still be plenty of market available for Cryoport as they cannot possibly have endless numbers of these machines available.
News 
Market Data 
Discover 
